LON:SENS

Sensyne Health - SENS Share Forecast, Price & News

GBX 0.35

-0.18 (-33.33%)

(As of 06/17/2022)

Add

Compare

Today's Range: 0.16
▼
0.60
50-Day Range: 0.35
▼
1
52-Week Range: 0.16
▼
155

Volume: 4.45 million shs
Average Volume: 3.45 million shs
Market Capitalization: £582,624.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: GBX 310

About Sensyne Health (LON:SENS) Stock

Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles, UK data protection law and applicable regulatory guidance. Sensyne Health is an early signatory to the Department of Health and Social Care’s ‘Initial Code of Conduct for data-driven health and care technology’.

Receive SENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensyne Health and its competitors with MarketBeat's FREE daily newsletter.

SENS Stock News Headlines

July 9, 2022 | msn.com

Why Oxford biotech needs more than a shot in the arm to survive

July 6, 2022 | msn.com

Health trusts swapped patient data for shares in an AI firm. They may have lost millions

May 21, 2022 | msn.com

Parmy Olson: Medical care increasingly depends on health tech AI. That may not be good for you.

May 11, 2022 | washingtonpost.com

Too Much AI May Not Be Good for Your Health or the NHS

April 19, 2022 | lse.co.uk

AIM WINNERS & LOSERS: Cake Box trading strong; Sensyne falls further

April 19, 2022 | marketwatch.com

Sensyne Health Ends Sale Process, to Delist From AIM

April 19, 2022 | lse.co.uk

Sensyne Health shares plummet as AIM delisting proposed

April 19, 2022 | proactiveinvestors.com

Sensyne Health ends sale process as refinancing plans are fleshed out

April 13, 2022 | markets.businessinsider.com

Form 8.3 - Lupus alpha Asset Management AG: Sensyne Health PLC

April 8, 2022 | lse.co.uk

Sensyne Health dives as it warns of future; chief executive steps down

April 8, 2022 | finance.yahoo.com

U.K. Labour Peer’s Data Firm Drops 89% on Shareholder Wipeout

April 8, 2022 | uk.finance.yahoo.com

Former Labour minister ousted from Sensyne Health

April 8, 2022 | marketwatch.com

Shares in Sensyne Dive After It Warns on Future, Amends Financing Agreement

April 8, 2022 | lse.co.uk

AIM WINNERS & LOSERS: Sensyne Health drops amid AIM delisting warning

April 8, 2022 | lse.co.uk

UPDATE: Sensyne Health plunges amid AIM delisting warning

April 8, 2022 | proactiveinvestors.com

Sensyne Health CEO departs; new financing deal provisionally agreed

February 7, 2022 | finance.yahoo.com

Form 8.3 - Sensyne Health Ltd

January 31, 2022 | lse.co.uk

Sensyne reports "disappointing" first half, with revenue decline

January 31, 2022 | proactiveinvestors.com.au

Sensyne Health strengthens the foundations for future growth in revenues

January 31, 2022 | marketwatch.com

Sensyne Health 1H Pretax Loss Widened, Revenue Fell After Disappointing Commercial Progress

January 26, 2022 | lse.co.uk

AIM WINNERS & LOSERS: IG Design plunges after profit warning

January 26, 2022 | lse.co.uk

Sensyne shares rise after securing much-needed GBP11 million

January 19, 2022 | uk.finance.yahoo.com

Invesco Ltd.: Form 8.3 - Sensyne Health Plc.

January 14, 2022 | ft.com

Sensyne shares plummet after warning over cash

January 14, 2022 | lse.co.uk

Sensyne shares drop as it seeks shareholder funds to continue trading

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive SENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensyne Health and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Health Information Services
Sub-Industry: N/A
Sector: Computer and Technology
Current Symbol: LON:SENS
CUSIP: N/A
CIK: N/A
Web: www.sensynehealth.com
Phone: 44 3300 581845
Fax: N/A
Employees: 70
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: GBX 310
High Stock Price Forecast: GBX 310
Low Stock Price Forecast: GBX 310
Forecasted Upside/Downside: +88,471.4%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: 5.83
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 6.02
Current Ratio: 2.26
Quick Ratio: 2.26

Sales & Book Value

Annual Sales: £7.81 million
Price / Sales: 0.07
Cash Flow: GBX 4.90 per share
Price / Cash Flow: 0.07
Book Value: GBX 20.30 per share
Price / Book: 0.02

Miscellaneous

Outstanding Shares: 166,464,000
Free Float: N/A
Market Cap: £582,624.00
Optionable: Optionable
Beta: N/A

Key Competitors

View All Competitors

SENS Stock - Frequently Asked Questions

Should I buy or sell Sensyne Health stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sensyne Health in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SENS shares.
View SENS analyst ratings or view top-rated stocks.
What is Sensyne Health's stock price forecast for 2022?: 1 analysts have issued 1 year price targets for Sensyne Health's shares. Their SENS share price forecasts range from GBX 310 to GBX 310. On average, they expect the company's stock price to reach GBX 310 in the next twelve months. This suggests a possible upside of 88,471.4% from the stock's current price.
View analysts price targets for SENS or view top-rated stocks among Wall Street analysts.
How have SENS shares performed in 2022?: Sensyne Health's stock was trading at GBX 80.49 at the start of the year. Since then, SENS stock has decreased by 99.6% and is now trading at GBX 0.35.
View the best growth stocks for 2022 here.
What other stocks do shareholders of Sensyne Health own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Sensyne Health investors own include Fresenius Medical Care AG & Co. KGaA (FME), Green Plains Partners (GPP), Hershey (HSY), Gilead Sciences (GILD), Griffon (GFF), Emerald (EEX), DHX Media (DHXM), Ctrip.Com International (CTRP), Corus Entertainment (CJR) and Citizens Financial Group (CFG).

What is Sensyne Health's stock symbol?: Sensyne Health trades on the London Stock Exchange (LON) under the ticker symbol "SENS."
How do I buy shares of Sensyne Health?: Shares of SENS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is Sensyne Health's stock price today?: One share of SENS stock can currently be purchased for approximately GBX 0.35.
How much money does Sensyne Health make?: Sensyne Health (LON:SENS) has a market capitalization of £582,624.00 and generates £7.81 million in revenue each year.
How can I contact Sensyne Health?: The official website for the company is www.sensynehealth.com. The company can be reached via phone at 44 3300 581845.

This page (LON:SENS) was last updated on 8/10/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources